Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

PERRIGO COMPANY PLC

(PRGO)
  Report
Delayed Nyse  -  04:00 2022-09-23 pm EDT
38.09 USD   -1.35%
09/20US FDA Commits to Strengthening Infant Formula Supply
MT
09/14Argus Upgrades Perrigo to Buy From Hold; Price Target is $46
MT
09/12Perrigo Says FDA to Review Oral Contraceptive Pill for Over-the-Counter Use in November
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Perrigo Company plc Reports Earnings Results for the Second Quarter and Six Months Ended July 02, 2022

08/09/2022 | 03:56pm EDT

Perrigo Company plc reported earnings results for the second quarter and six months ended July 02, 2022. For the second quarter, the company reported sales was USD 1,121.7 million compared to USD 981.1 million a year ago. Net loss was USD 65.1 million compared to USD 57.7 million a year ago. Basic loss per share from continuing operations was USD 0.48 compared to USD 0.84 a year ago. Diluted loss per share from continuing operations was USD 0.48 compared to USD 0.84 a year ago. Basic loss per share was USD 0.48 compared to USD 0.43 a year ago. Diluted loss per share was USD 0.48 compared to USD 0.43 a year ago.
For the six months, sales was USD 2,196.2 million compared to USD 1,991.1 million a year ago. Net loss was USD 67.6 million compared to USD 19.6 million a year ago. Basic loss per share from continuing operations was USD 0.49 compared to USD 0.82 a year ago. Diluted loss per share from continuing operations was USD 0.49 compared to USD 0.82 a year ago. Basic loss per share was USD 0.5 compared to USD 0.15 a year ago. Diluted loss per share was USD 0.5 compared to USD 0.15 a year ago.


© S&P Capital IQ 2022
Stocks mentioned in the article
ChangeLast1st jan.
PAX DOLLAR (USDP/USD) 0.20% 1.001 End-of-day quote.0.11%
PERRIGO COMPANY PLC -1.35% 38.09 Delayed Quote.-2.08%
All news about PERRIGO COMPANY PLC
09/20US FDA Commits to Strengthening Infant Formula Supply
MT
09/14Argus Upgrades Perrigo to Buy From Hold; Price Target is $46
MT
09/12Perrigo Says FDA to Review Oral Contraceptive Pill for Over-the-Counter Use in November
MT
09/12U.S. FDA to review Perrigo's birth control pill for OTC use in November
RE
09/12Perrigo announces joint fda advisory committee to review opill® daily oral contraceptiv..
PR
09/06Perrigo Company Shares Rise After Wells Fargo Upgrade
MT
09/06Wells Fargo Raises Perrigo to Overweight From Equalweight, Price Target to $54 From $48
MT
09/01PERRIGO COMPANY PLC : Ex-dividend day for
FA
08/17Perrigo Refutes Involvement in Recent Notice of Dismissal of Claims, Impending Trial Ov..
MT
08/17Perrigo releases statement on recent market trading activity
PR
More news
Analyst Recommendations on PERRIGO COMPANY PLC
More recommendations
Financials (USD)
Sales 2022 4 540 M - -
Net income 2022 -111 M - -
Net Debt 2022 3 689 M - -
P/E ratio 2022 -55,6x
Yield 2022 2,84%
Capitalization 5 128 M 5 128 M -
EV / Sales 2022 1,94x
EV / Sales 2023 1,77x
Nbr of Employees 9 900
Free-Float 99,0%
Chart PERRIGO COMPANY PLC
Duration : Period :
Perrigo Company plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PERRIGO COMPANY PLC
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 38,09 $
Average target price 51,50 $
Spread / Average Target 35,2%
EPS Revisions
Managers and Directors
Murray S. Kessler President, Chief Executive Officer & Director
Eduardo Guarita Bezerra Chief Financial Officer & Executive Vice President
Orlando D. Ashford Chairman
Thomas M. Farrington Chief Information Officer & Executive VP
Grainne Quinn Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capi. (M$)
PERRIGO COMPANY PLC-2.08%5 128
JOHNSON & JOHNSON-2.54%438 337
ELI LILLY AND COMPANY12.54%295 941
ROCHE HOLDING AG-18.41%259 291
ABBVIE INC.5.66%252 944
PFIZER, INC.-25.35%247 392